Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis.

Metsios GS, Moe RH, van der Esch M, van Zanten JJCSV, Fenton SAM, Koutedakis Y, Vitalis P, Kennedy N, Brodin N, Bostrom C, Swinnen TW, Tzika K, Niedermann K, Nikiphorou E, Fragoulis GE, Vlieland TPVM, Van den Ende CHM, Kitas GD; IMPACT-RMD Consortium.

Rheumatol Int. 2019 Dec 4. doi: 10.1007/s00296-019-04483-6. [Epub ahead of print] Review.

PMID:
31802210
2.

Zoledronic acid in nine patients with transient osteoporosis of the hip.

Evangelatos G, Fragoulis GE, Iliopoulos A.

Clin Rheumatol. 2019 Nov 23. doi: 10.1007/s10067-019-04840-7. [Epub ahead of print] No abstract available.

PMID:
31760542
3.

Development of generic core competences of health professionals in rheumatology: a systematic literature review informing the 2018 EULAR recommendations.

Fragoulis GE, Edelaar L, Vliet Vlieland TPM, Iagnocco A, Schäfer VS, Haines C, Schoones J, Nikiphorou E.

RMD Open. 2019 Oct 23;5(2):e001028. doi: 10.1136/rmdopen-2019-001028. eCollection 2019. Review.

4.

Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.

Fragoulis GE, Nikiphorou E, Larsen J, Korsten P, Conway R.

Front Med (Lausanne). 2019 Oct 23;6:238. doi: 10.3389/fmed.2019.00238. eCollection 2019. Review.

5.

Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?

Evangelatos G, Fragoulis GE, Iliopoulos A.

Ann Rheum Dis. 2019 Nov 5. pii: annrheumdis-2019-216527. doi: 10.1136/annrheumdis-2019-216527. [Epub ahead of print] No abstract available.

PMID:
31690621
6.

MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact.

Evangelatos G, Fragoulis GE, Koulouri V, Lambrou GI.

Autoimmun Rev. 2019 Nov;18(11):102391. doi: 10.1016/j.autrev.2019.102391. Epub 2019 Sep 11. Review.

PMID:
31520804
7.

Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature.

Fragoulis GE, Conway R, Nikiphorou E.

Rheumatology (Oxford). 2019 Nov 1;58(11):1900-1906. doi: 10.1093/rheumatology/kez337.

PMID:
31504978
8.

When rheumatology and infectious disease come together.

Fragoulis GE, Sipsas NV.

Ther Adv Musculoskelet Dis. 2019 Aug 22;11:1759720X19868901. doi: 10.1177/1759720X19868901. eCollection 2019. No abstract available.

9.

Zoledronic acid is effective and safe in migratory osteoporosis.

Evangelatos G, Fragoulis GE, Zampeli E, Kechagia M, Iliopoulos A.

Rheumatology (Oxford). 2019 Aug 14. pii: kez345. doi: 10.1093/rheumatology/kez345. [Epub ahead of print] No abstract available.

PMID:
31411329
10.

2019 EULAR recommendations for the generic core competences of health professionals in rheumatology.

Edelaar L, Nikiphorou E, Fragoulis GE, Iagnocco A, Haines C, Bakkers M, Barbosa L, Cikes N, Ndosi M, Primdahl J, Prior Y, Pchelnikova P, Ritschl V, Schäfer VS, Smucrova H, Storrønning I, Testa M, Wiek D, Vliet Vlieland TPM.

Ann Rheum Dis. 2019 Aug 9. pii: annrheumdis-2019-215803. doi: 10.1136/annrheumdis-2019-215803. [Epub ahead of print]

PMID:
31399400
11.

Takayasu arteritis: "bitten apple" in the aorta, odd finding in a plain X-ray.

Fragoulis GE, Evangelatos G, Iliopoulos A.

Clin Rheumatol. 2019 Nov;38(11):3307-3308. doi: 10.1007/s10067-019-04711-1. Epub 2019 Aug 2. No abstract available.

PMID:
31372854
12.

Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.

Fragoulis GE, Panayotidis I, Nikiphorou E.

Curr Vasc Pharmacol. 2019 Jun 19. doi: 10.2174/1570161117666190619143842. [Epub ahead of print]

PMID:
31258091
13.

Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.

Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T.

World J Gastroenterol. 2019 May 14;25(18):2162-2176. doi: 10.3748/wjg.v25.i18.2162. Review.

14.

Twenty-year scintigraphic follow-up of calcitonin versus zoledronic acid in Paget's disease of bones.

Evangelatos G, Fragoulis GE, Iliopoulos A.

Rheumatology (Oxford). 2019 Oct 1;58(10):1776. doi: 10.1093/rheumatology/kez070. No abstract available.

PMID:
30879052
15.

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis.

Fragoulis GE, McInnes IB, Siebert S.

Rheumatology (Oxford). 2019 Feb 1;58(Supplement_1):i43-i54. doi: 10.1093/rheumatology/key276.

16.

Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome.

Fragoulis GE, Paterson C, Gilmour A, Derakhshan MH, McInnes IB, Porter D, Siebert S.

RMD Open. 2018 Oct 8;4(2):e000739. doi: 10.1136/rmdopen-2018-000739. eCollection 2018.

17.

Inflammation, obesity and rheumatic disease: common mechanistic links. A narrative review.

Nikiphorou E, Fragoulis GE.

Ther Adv Musculoskelet Dis. 2018 Jun 27;10(8):157-167. doi: 10.1177/1759720X18783894. eCollection 2018 Aug. Review.

18.

Hyper-IgD syndrome in a patient with IgA immunodeficiency.

Smerla RG, Agrafiotou C, Fragoulis GE.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):934. Epub 2018 Jul 19. No abstract available.

19.

Transient Osteoporosis of the Hip Mimicking Flare of Psoriatic Arthritis.

Evangelatos G, Fragoulis GE, Iliopoulos A.

J Clin Rheumatol. 2018 Jul 20. doi: 10.1097/RHU.0000000000000867. [Epub ahead of print] No abstract available.

PMID:
30028805
20.

Autoimmune or infectious disease? That is the question.

Constantinou CA, Fragoulis GE, Gakiopoulou Η, Tzioufas AG, Sipsas NV.

Clin Exp Rheumatol. 2018 May-Jun;36(3):517-518. Epub 2018 Mar 27. No abstract available.

PMID:
29600934
21.

Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report.

Smerla RG, Rontogianni D, Fragoulis GE.

Clin Rheumatol. 2018 Jun;37(6):1721-1727. doi: 10.1007/s10067-017-3934-9. Epub 2017 Dec 4. Review.

PMID:
29204759
22.

Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study.

Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG.

Clin Rheumatol. 2018 Mar;37(3):737-747. doi: 10.1007/s10067-017-3835-y. Epub 2017 Sep 15.

PMID:
28914375
23.

Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Lionaki S, Fragoulis GE, Venetsanopoulou A, Vlachoyiannopoulos P, Boletis JN, Tzioufas AG.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):155-164. Epub 2017 Jan 25.

PMID:
28134075
24.

Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome.

Fragoulis GE, Fragkioudaki S, Reilly JH, Kerr SC, McInnes IB, Moutsopoulos HM.

J Autoimmun. 2016 Sep;73:85-91. doi: 10.1016/j.jaut.2016.06.008. Epub 2016 Jun 22.

PMID:
27344240
25.

IgG4-related sialadenitis and Sjögren's syndrome.

Fragoulis GE, Zampeli E, Moutsopoulos HM.

Oral Dis. 2017 Mar;23(2):152-156. doi: 10.1111/odi.12526. Epub 2016 Jul 14. Review.

PMID:
27318181
26.

Panniculitis: an unusual presenting manifestation of rheumatoid arthritis.

Fragoulis GE, Stamopoulos P, Barbatis C, Tzioufas AG.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):126-8. Epub 2016 Jan 8.

PMID:
26742648
27.

Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.

Fragoulis GE, Siebert S, McInnes IB.

Annu Rev Med. 2016;67:337-53. doi: 10.1146/annurev-med-051914-021944. Epub 2015 Nov 4. Review.

PMID:
26565676
28.

Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis.

Mavragani CP, Fragoulis GE, Somarakis G, Drosos A, Tzioufas AG, Moutsopoulos HM.

Medicine (Baltimore). 2015 May;94(21):e829. doi: 10.1097/MD.0000000000000829.

29.

Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome.

Manoussakis MN, Fragoulis GE, Vakrakou AG, Moutsopoulos HM.

PLoS One. 2014 Nov 14;9(11):e112100. doi: 10.1371/journal.pone.0112100. eCollection 2014.

30.

Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.

Fragoulis GE, Vakrakou AG, Papadopoulou A, Germenis A, Kanavakis E, Moutsopoulos HM, Manoussakis MN.

J Autoimmun. 2015 Jan;56:12-22. doi: 10.1016/j.jaut.2014.08.004. Epub 2014 Sep 16.

PMID:
25228497
31.

Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease?

Mavragani CP, Fragoulis GE, Rontogianni D, Kanariou M, Moutsopoulos HM.

Arthritis Care Res (Hoboken). 2014 May;66(5):773-7. doi: 10.1002/acr.22216.

32.

Endocrine alterations in primary Sjogren's syndrome: an overview.

Mavragani CP, Fragoulis GE, Moutsopoulos HM.

J Autoimmun. 2012 Dec;39(4):354-8. doi: 10.1016/j.jaut.2012.05.011. Epub 2012 Jun 12. Review.

PMID:
22695186
33.

IgG4 syndrome: old disease, new perspective.

Fragoulis GE, Moutsopoulos HM.

J Rheumatol. 2010 Jul;37(7):1369-70. doi: 10.3899/jrheum.100383. No abstract available.

PMID:
20595288
34.

Prevalence and longterm course of primary biliary cirrhosis in primary Sjögren's syndrome.

Hatzis GS, Fragoulis GE, Karatzaferis A, Delladetsima I, Barbatis C, Moutsopoulos HM.

J Rheumatol. 2008 Oct;35(10):2012-6. Epub 2008 Aug 15.

PMID:
18709690
35.

Is mizoribine a new therapeutic agent for Sjögren's syndrome?

Moutsopoulos HM, Fragoulis GE.

Nat Clin Pract Rheumatol. 2008 Jul;4(7):350-1. doi: 10.1038/ncprheum0823. Epub 2008 May 27.

PMID:
18506160

Supplemental Content

Loading ...
Support Center